HH-003
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HH-003, covering 2023-09-28 to 2024-10-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Antiviral Activity and Safety of HH-003 in Chronic Hepatitis B Subjects With Low-level Viremia [Phase 2]